Affimed Enters into Collaboration with Merck to Evaluate AFM13 in Combination with KEYTRUDA® (pembrolizumab) for Patients with Hodgkin Lymphoma
January 25, 2016
January 25, 2016
January 21, 2016
January 20, 2016
January 12, 2016
December 14, 2015
December 6, 2015
December 6, 2015
December 2, 2015
December 1, 2015
November 11, 2015